Breast implant market to grow 10% a year through 2012, according to Millennium
Research Group
WALTHAM, Mass., Jan. 16 /PRNewswire/ -- According to Millennium Research
Group's Global Markets for Breast Implants 2008 report, the US breast implant
market, worth over $378 million in 2007, will grow to over $620 million in
2012, driven in large part by the Food and Drug Administration's (FDA)
reapproval of silicone breast implants. In addition, fourth-generation
silicone breast implants, known as "gummybear" implants, are set to take off
over the next five years and will further drive market growth. Gummybear
implants eliminate the potential for gel migration because of the extremely
cohesive nature of the material inside.
In 1992, silicone breast implants were taken off the US market because of
concerns that leakages could lead to various connective tissue diseases or
cancer. A four-year study of the implants, however, determined that the
devices are safe for use, which resulted in the November 2006 FDA reapproval
of the products. This decision has generated excitement among US surgeons and
patients alike, many of whom believe that these implants mimic breast tissue
better than saline and therefore result in a more natural look and feel to the
breast.
"Over the next five years, increased societal acceptance of breast
augmentation procedures as well as penetration of higher-priced silicone
implants will drive market growth," says Aviva Shedletzky, Analyst at
Millennium Research Group. "By 2012, nearly 80% of breast implants sold in the
US will be silicone. Given that these products command approximately double
the price of the saline alternative, revenues will increase."
The Global Markets for Breast Implants 2008 report provides coverage of
the US, Canada, Spain, Germany, France, Italy, UK, Brazil, Mexico, Argentina,
China, Australia, Japan, South Korea, Thailand, and India. Selected companies
covered in this report include Allergan, Mentor, Silimed (Sientra), and
Eurosilicone, and many others.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.
company (www.DecisionResources.com), is the global authority on medical
technology market intelligence and a leading provider of strategic information
to the health care sector. Focused solely on the medical device,
pharmaceutical, and biotechnology industries, the company provides its clients
with the benefits of its specialized industry expertise through published
reports and customized consulting services.
All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net
SOURCE Millennium Research Group
Amy Krohn of Millennium Research Group, +1-416-364-7776, ext. 101,
akrohn@mrg.net
